Beacon Biosignals
Boston, United States · Information Technology, Software
Beacon's machine learning platform for EEG enables and accelerates new treatments that transform the lives of patients with neurological, psychiatric or sleep disorders. Through novel machine learning algorithms, large datasets, and advances in software engineering, Beacon Biosignals is changing the way patients are treated for disorders of the brain.
You have opened 5 full company profiles today. Create an account to keep reading them. Create an account
Key facts
- Headquarters
- Boston, United States
- Employees
- 103
- Industries
- Information Technology, Software
- Status
- Private
- Website
- beacon.bio
- Company page
Recent activity at Beacon Biosignals
- : Beacon Biosignals raises $11M in a Series B extension, bringing total funding to over $97M. New investors include JSL Health, Palo Santo VC, Kicker Ventures, and Samsung Next.
- : Beacon Biosignals raises $86M in Series B funding led by Innoviva and Google Ventures to scale its technology for neurobiomarker discovery.
- : Beacon Biosignals Launches FDA-Authorized Dreem 3S Sleep Wearable with Continuous Improvement Capabilities.
Employee benefit plans
Beacon Biosignals files 1 employee benefit plan with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
About Beacon Biosignals: questions and answers
What does Beacon Biosignals do?
Beacon's machine learning platform for EEG enables and accelerates new treatments that transform the lives of patients with neurological, psychiatric or sleep disorders. Through novel machine learning algorithms, large datasets, and advances in software engineering, Beacon Biosignals is changing the way patients are treated for disorders of the brain.
Where is Beacon Biosignals headquartered?
Beacon Biosignals is headquartered in Boston, United States.
How many employees does Beacon Biosignals have?
Beacon Biosignals has about 103 employees.
What is the latest news on Beacon Biosignals?
On Apr 06, 2026, Beacon Biosignals raises $11M in a Series B extension, bringing total funding to over $97M. New investors include JSL Health, Palo Santo VC, Kicker Ventures, and Samsung Next.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy